Secondly, the risk prediction models incorporating stemness, methylation, and moonlighting genes associated with YBX1 can furnish valuable insights into the prognosis and survival of tumor patients, serving as pivotal prognostic tools for predicting outcomes and survival rates [120,121,122,123,124]. The gene discussed is YBX1; the disease is neoplasm.